Colgate-Palmolive (CL) is back in focus after reporting a strong start to 2026. Revenue and earnings both improved, analysts’ revenue estimates were exceeded, and gross margin expanded compared with the prior quarter.

At a share price of $89.39, Colgate-Palmolive has a year to date share price return of 15.06%, while the 1 year total shareholder return is slightly down 1.60%. This suggests recent momentum has picked up even as longer term returns remain more modest.

If Colgate-Palmolive’s recent move has you thinking about where else capital is flowing, this is a good moment to scan 20 top founder-led companies

The stock now trades close to analysts’ targets yet carries an estimated intrinsic value gap, raising a key question for you: Is Colgate-Palmolive still undervalued here, or is the market already pricing in future growth?

Most Popular Narrative: 7.5% Undervalued

Colgate-Palmolive’s most followed narrative pegs fair value at $96.68, a little above the latest close of $89.39, which puts the current setup in context before looking at what is driving that view.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally, supporting top-line organic sales acceleration and improved pricing power.

Want to see what kind of revenue path and profit uplift this story is built on? The narrative leans on steadier growth, richer margins, and a valuation multiple that still assumes investors pay up for those earnings. Curious how those pieces fit together to reach $96.68 instead of $89.39 today?

Result: Fair Value of $96.68 (UNDERVALUED)

However, this story can still be knocked off course if higher raw material and packaging costs squeeze margins, or if weak demand in key markets limits revenue growth.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Rich Multiples Versus Cash Flow Upside

There is a twist here. Colgate-Palmolive screens as 25.5% below the Simply Wall St estimate of fair value on future cash flows, yet the stock trades on a P/E of 34.3x versus a fair ratio of 21.7x, 22x for peers, and 16.8x for the global household products group. Is that a margin of safety or a valuation risk if sentiment turns?

To see how those earnings multiples compare with detailed cash flow work, take a closer look at our valuation breakdown. This includes the fair ratio and illustrates where the share price could gravitate over time See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and concern feels familiar, treat it as your cue to move quickly and check the full picture of Colgate-Palmolive's story for yourself with 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If Colgate-Palmolive has sharpened your interest, do not stop here. Use this momentum to line up your next set of potential opportunities with focus.

• Target resilient balance sheets and steady fundamentals by scanning the solid balance sheet and fundamentals stocks screener (47 results) so your watchlist leans on financial strength.
• Hunt for quality at a discount by reviewing the 46 high quality undervalued stocks before prices move and the gap between value and market price narrows.
• Build a shortlist of overlooked opportunities by checking the screener containing 20 high quality undiscovered gems so you are not late to stories others only spot after they move.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.